Literature DB >> 1835339

Short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency in muscle: a new cause for recurrent myoglobinuria and encephalopathy.

I Tein1, D C De Vivo, D E Hale, J T Clarke, H Zinman, R Laxer, A Shore, S DiMauro.   

Abstract

We report on a 16-year-old girl with short-chain L-3-hydroxyacyl-coenzyme A (CoA) dehydrogenase deficiency resulting in juvenile-onset recurrent myoglobinuria, hypoketotic hypoglycemic encephalopathy, and hypertrophic/dilatative cardiomyopathy. Urinary organic acids showed traces of 3-hydroxy-dodecanedioic acids and small amounts of suberic, sebacic, and adipic acids. There was a marked decrease in L-3-hydroxyacyl-CoA dehydrogenase activity in muscle with acetoacetyl-CoA as substrate (2.48 mumol/min/gm; normal = 6.90 +/- 1.80 mumol/min/gm of tissue; n = 11), contrasting with normal L-3-hydroxyacyl-CoA dehydrogenase activity with 3-ketooctanoyl-CoA and 3-ketopalmitoyl-CoA as substrates. Short-chain L-3-hydroxyacyl-CoA dehydrogenase activity was normal in fibroblasts, suggesting a tissue-specific defect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835339     DOI: 10.1002/ana.410300315

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase.

Authors:  Changhong Li; Pan Chen; Andrew Palladino; Srinivas Narayan; Laurie K Russell; Samir Sayed; Guoxiang Xiong; Jie Chen; David Stokes; Yasmeen M Butt; Patricia M Jones; Heather W Collins; Noam A Cohen; Akiva S Cohen; Itzhak Nissim; Thomas J Smith; Arnold W Strauss; Franz M Matschinsky; Michael J Bennett; Charles A Stanley
Journal:  J Biol Chem       Date:  2010-07-29       Impact factor: 5.157

2.  Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: the clinical relevance of an early diagnosis and report of four new cases.

Authors:  Esmeralda Martins; M Luis Cardoso; Esmeralda Rodrigues; Clara Barbot; Altina Ramos; Michael J Bennett; Elisa Leão Teles; Laura Vilarinho
Journal:  J Inherit Metab Dis       Date:  2011-02-24       Impact factor: 4.982

Review 3.  Metabolic enzymes dysregulation in heart failure: the prospective therapy.

Authors:  Priyanka Parihar; Mordhwaj Singh Parihar
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

4.  Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion.

Authors:  P T Clayton; S Eaton; A Aynsley-Green; M Edginton; K Hussain; S Krywawych; V Datta; H E Malingre; R Berger; I E van den Berg
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 5.  Disorders of mitochondrial fatty acyl-CoA beta-oxidation.

Authors:  R J Wanders; P Vreken; M E den Boer; F A Wijburg; A H van Gennip; L IJlst
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

Review 6.  Mammalian mitochondrial beta-oxidation.

Authors:  S Eaton; K Bartlett; M Pourfarzam
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

7.  Skin fibroblast carnitine uptake in secondary carnitine deficiency disorders.

Authors:  I Tein; D C De Vivo; D Ranucci; S DiMauro
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

8.  Glucose-free medium exacerbates microvesicular steatosis in cultured skin fibroblasts of genetic defects of fatty acid oxidation. A novel screening test.

Authors:  D L Renaud; V Edwards; G J Wilson; I Tein
Journal:  J Inherit Metab Dis       Date:  2002-11       Impact factor: 4.982

Review 9.  New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders.

Authors:  P M Coates
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

10.  scully, an essential gene of Drosophila, is homologous to mammalian mitochondrial type II L-3-hydroxyacyl-CoA dehydrogenase/amyloid-beta peptide-binding protein.

Authors:  L Torroja; D Ortuño-Sahagún; A Ferrús; B Hämmerle; J A Barbas
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.